ConductScience.org, home

Trial · NCT03296579

Non-invasive Ventilation vs. Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma

NCT03296579, Not applicable, Unknown, University of British Columbia

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Non-invasive Ventilation vs. Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma. Trials, record NCT03296579. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03296579

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Non-invasive Ventilation vs. Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma
NCT number
NCT03296579
Status
Unknown
Phases
Not applicable
Enrollment
100 participants, estimated
Lead sponsor
University of British Columbia
Conditions
Asthma Acute, Asthma in Children
Interventions
BiPAP, CPAP, Ipratropium, Magnesium Sulfate, Aminophylline, Standard steroid dose, hourly salbutamol, oxygen as needed
First posted
2017-09-28
Last updated
2018-05-02

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTime to reach a PRAM score of ≤3Patients will be followed for the duration of their hospital stay (an estimated average duration of 4 days)PRAM score includes assessment of oxygen saturations, suprasternal retractions, scalene muscle contraction, air entry and wheezing.
SecondaryTime to room airPatients will be followed for the duration of their hospital stay (an estimated average of 4 days).Time that oxygen is required
SecondaryTotal medication use per 12 hr periodPatients will be followed for the duration of their hospital stay (an estimated average of 4 days).Comparison of total medication use by children in each arm.
SecondaryNumbers failing treatment and transferred to ICUPatients will be followed for the duration of their hospital stay (an estimated average of 4 days).Number of patients in each group that fail treatment and require transfer to ICU
OtherTime to reach FEV1 >80% predicted in those children able to perform pulmonary function testsPatients will be followed for the duration of their hospital stay (an estimated average of 4 days).Standard pulmonary function tests can usually be performed by children \>6 years.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers10

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
11867822BACKGROUNDPubMed
18346499BACKGROUNDPubMed
19616722BACKGROUNDPubMed
19911854BACKGROUNDPubMed
20956164BACKGROUNDPubMed
22067982BACKGROUNDPubMed
23798903BACKGROUNDPubMed
24041942BACKGROUNDPubMed
24925892BACKGROUNDPubMed
28139368BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03296579

GET https://conductscience.org/api/trials/v1/NCT03296579/registered